NXGL · Nexgel, Inc.
$5.33
-0.47 (-8.10%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an unrestricted cash balance of $0.5 million. For the six months ended June 30, 2026, the Company incurred a net loss of $4.5 million and had a net usage of cash in operating activities of $2,701 thousand. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 17, 2026
Market Cap
$2.60M
Shares
487,383
Volume · Oct 20
28.73K
Avg daily vol (7 sessions)
559.91K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.33
Open$5.80
Day$4.50–5.80
52W close$3.00–55.60
Avg vol 30d167K
Short int16K · 3.3% float · 1.0d
Short vol34%
Last earningsNov 12, 2025
DataDec 2021–Oct 2026
Filing10-Q · Aug 17
Up next
filed Aug 17, 2026
call held Nov 12, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$12.07M
Trailing 12 months
Net income (TTM)
−$6.22M
Trailing 12 months
Revenue growth YoY
+27.8%
Year over year
Operating margin
-44.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.56M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+17.8%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
3.3%
Latest settlement · 1.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−61%
below
Price vs 50-day avg
−8%
below
RSI (14)
54
neutral
MACD trend
Positive
52-week position
4%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−3%
trailing
6-month return
−56%
trailing
YTD return
−83%
this year
Relative strength
−64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $14 — 200d above 50d
Institutional flow
Accumulating
+9% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.31% of float · ▲ +63.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
24 holders — mid 3-yr range
Squeeze score
63
elevated · 0–100
Fundamentals
Revenue growth
+31%
Y/Y
Gross margin
39%
expanding
EPS growth
+24%
Y/Y
Free cash flow
$-1.4M
Quant / Vol
risk profile
Volatility
125%
annualized · 1-yr
Max drawdown
−95%
past year
ATR
16.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the Earnings Call filed Nov 12, 2025
Full year 2025 revenues
· full year 2025
$12M – $12.5M
Guided vs delivered
· last 3 settled
Full year 2025 revenues
full year 2025
guided $12M – $12.5M
$11.42M
Miss −6.8%
Revenue
third quarter of 2024
guided $2.2M
$2.94M
Beat +33.6%
Revenue
fourth quarter of 2024
guided $2.6M
$3.04M
Beat +17.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−61%
Bearish
Price vs 50-day avg
−8%
Bearish
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
4%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $6 › 200d $14 — 200d above 50d
Institutional flow
Accumulating
+9% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.31% of float · ▲ +63.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
24 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3
Now $5 · 4%
Range high $56
vs 200-day avg -61%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NXGL
this stock
Nexgel, Inc.
|
$2.60M | — | +31.5% | — | 3.3% |
|
ISRG
Intuitive Surgical Inc
|
$154.74B | -22.7% | +20.5% | 50.3 | 2.1% |
|
BDX
Becton Dickinson & Co
|
$52.60B | — | +8.2% | — | 3.6% |
|
MDLN
Medline Inc.
|
$46.62B | -15.6% | +11.5% | — | 4.0% |
|
RMD
Resmed Inc
|
$35.41B | +1.9% | +13.4% | 23.5 | 8.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NXGL | +31.6% | -3.1% | -55.6% | +54.1% | -83.5% |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | +32.8% | -2.5% | -63.7% | +53.2% | -96.2% |